Moses Joloba

Prof. Moses Joloba is the current Chair of the Department of Medical Microbiology, Makerere University College of Health Sciences. He is the current Head of Laboratories and also heads the appointments and promotions committee of the department. Dr Joloba completed his MbChB at Makerere University Medical School, Kampala, Uganda, in 1994, did his Master of Science in Microbiology in 1996 and PhD in Molecular Microbiology 2003 at Case Western Reserve University, Cleveland,Ohio, USA, In 2001, he joined Makerere University College of Health Sciences as a faculty member, and in 2003 he established the Molecular Biology laboratory in the Department of Medical Microbiology. This laboratory focused on TB research and in 2006, molecular detection of MTC infections as a routine was introduced for the first time in Ugandan research labs. Dr Joloba has won grants from WHO/TDR, SIDA-SAREC, NIH, EDCTP and the European Union for TB research ranging from basic to applied and clinical. His research focus is bacterial quorum sensing, TB-molecular epidemiology and drug resistance. Publications: 1. Albert H, Ademun PJ, Lukyamuzi G, Nyesiga B, Manabe Y, Joloba M, Wilson S, Perkins MD. Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy. BMC Infect Dis. 2011 May 13;11:125. PMID: 21569474 [PubMed - indexed for MEDLINE] 2. Albert H, Bwanga F, Mukkada S, Nyesiga B, Ademun JP, Lukyamuzi G, Haile M, Hoffner S, Joloba M, O'Brien R. Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infect Dis. 2010 Feb 26;10:41. PMID: 20187922 [PubMed - indexed for MEDLINE] 3. Albert H, Manabe Y, Lukyamuzi G, Ademun P, Mukkada S, Nyesiga B, Joloba M, Paramasivan CN, Perkins MD. Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda. PLoS One. 2010 Dec 28;5(12):e15206. PMID: 21203398[PubMed - indexed for MEDLINE] 4. Angra P, Becx-Bleumink M, Gilpin C, Joloba M, Jost K, Kam KM, Kim SJ, Lumb R, Mitarai S, Ramsay A, Ridderhof J, Rieder HL, Selvakumar N, van Beers S, van Cleeff M, Van Deun A, Vincent V. Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue?Int J Tuberc Lung Dis. 2007 Nov;11(11):1160-1. No abstract available. PMID:17958975 [PubMed - indexed for MEDLINE] 5. Asiimwe BB, Asiimwe J, Kallenius G, Ashaba FK, Ghebremichael S, Joloba M, Koivula T. Molecular characterisation of Mycobacterium bovis isolates from cattle carcases at a city slaughterhouse in Uganda. Vet Rec. 2009 May 23;164(21):655-8. PMID: 19465755 [PubMed - indexed for MEDLINE] 6. Asiimwe BB, Joloba ML, Ghebremichael S, Koivula T, Kateete DP, Katabazi FA, Pennhag A, Petersson R, Kallenius G. DNA restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from HIV-seropositive and HIV-seronegative patients in Kampala, Uganda. BMC Infect Dis. 2009 Feb 5;9:12. PMID: 19196450 [PubMed - indexed for MEDLINE] 7. Asiimwe BB, Ghebremichael S, Kallenius G, Koivula T, Joloba ML. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda. BMC Infect Dis. 2008 Jul 28;8:101. PMID:18662405 [PubMed - indexed for MEDLINE] 8. Asiimwe BB, Koivula T, K├ñllenius G, Huard RC, Ghebremichael S, Asiimwe J, Joloba ML.Mycobacterium tuberculosis Uganda genotype is the predominant cause of TB in Kampala, Uganda. Int J Tuberc Lung Dis. 2008 Apr;12(4):386-91. PMID: 18371263 [PubMed - indexed for MEDLINE] 9. Bark CM, Okwera A, Joloba ML, Thiel BA, Nakibali JG, Debanne SM, Boom WH, Eisenach KD, Johnson JL. Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures. Tuberculosis (Edinb). 2011 May;91(3):257-9. Epub 2011 Feb 25. PMID: 21353641 [PubMed - indexed for MEDLINE] 10. Bazira J, Asiimwe BB, Joloba ML, Bwanga F, Matee MI. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda. BMC Infect Dis. 2011 Mar 31;11:81. PMID: 21453482 [PubMed - indexed for MEDLINE] 11. Bazira J, Matte M, Asiimwe BB, Joloba LM. Genetic diversity of Mycobacterium tuberculosis in Mbarara, South Western Uganda. Afr Health Sci. 2010 Dec;10(4):306-11. PMID: 21416030 [PubMed - indexed for MEDLINE] 12. Bazira J, Asiimwe BB, Joloba ML, Bwanga F, Matee MI. Use of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda. BMC Clin Pathol. 2010 Aug 6;10:5. PMID: 20691055 [PubMed] 13. Berg S, Garcia-Pelayo MC, M├╝ller B, Hailu E, Asiimwe B, Kremer K, Dale J, Boniotti MB, Rodriguez S, Hilty M, Rigouts L, Firdessa R, Machado A, Mucavele C, Ngandolo BN, Bruchfeld J, Boschiroli L, M├╝ller A, Sahraoui N, Pacciarini M, Cadmus S, Joloba M, van Soolingen D, Michel AL, Dj├©nne B, Aranaz A, Zinsstag J, van Helden P, Portaels F, Kazwala R, K├ñllenius G, Hewinson RG, Aseffa A, Gordon SV, Smith NH. African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa. J Bacteriol. 2011 Feb;193(3):670-8. Epub 2010 Nov 19. Erratum in: J Bacteriol. 2012 Mar;194(6):1641. PMID:21097608 [PubMed - indexed for MEDLINE] 14. Blossom DB, Cordeiro SM, Bajaksouzian S, Joloba ML, Kityo C, Whalen CC, Salata RA, Jacobs MR. Characterization of penicillin intermediate serotypes of Streptococcus pneumoniae carried by human immunodeficiency virus-infected adults and healthy children in Uganda. Microb Drug Resist. 2007 Spring;13(1):21-8. PMID: 17536930 [PubMed - indexed for MEDLINE] 15. Blossom DB, Namayanja-Kaye G, Nankya-Mutyoba J, Mukasa JB, Bakka H, Rwambuya S, Windau A, Bajaksouzian S, Walker CJ, Joloba ML, Kityo C, Mugyenyi P, Whalen CC, Jacobs MR, Salata RA. Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility. Int J Infect Dis. 2006 Nov;10(6):458-64. Epub 2006 Sep 25. PMID: 16997591 [PubMed - indexed for MEDLINE] 16. Bwanga F, Haile M, Joloba ML, Ochom E, Hoffner S. Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda. PLoS One. 2011 May 9;6(5):e19565. PMID: 21573015 [PubMed - indexed for MEDLINE] 17. Bwanga F, Joloba ML, Haile M, Hoffner S. Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda. Int J Tuberc Lung Dis. 2010 Jul;14(7):890-5. PMID: 20550774 [PubMed - indexed for MEDLINE] 18. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis. 2009 May 20;9:67. Review. PMID: 19457256 [PubMed - indexed for MEDLINE] 19. Cattamanchi A, Davis JL, Worodria W, den Boon S, Yoo S, Matovu J, Kiidha J, Nankya F, Kyeyune R, Byanyima P, Andama A, Joloba M, Osmond DH, Hopewell PC, Huang L. Sensitivity and specificity of fluorescence microscopy for diagnosing pulmonary tuberculosis in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2009 Sep;13(9):1130-6. PMID: 19723403 [PubMed - indexed for MEDLINE] 20. Cattamanchi A, Dowdy DW, Davis JL, Worodria W, Yoo S, Joloba M, Matovu J, Hopewell PC, Huang L. Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis. 2009 May 6;9:53. PMID: 19419537 [PubMed - indexed for MEDLINE] 21. Cattamanchi A, Davis JL, Worodria W, Yoo S, Matovu J, Kiidha J, Nankya F, Kyeyune R, Andama A, Joloba M, Osmond D, Hopewell P, Huang L. Poor performance of universal sample processing method for diagnosis of pulmonary tuberculosis by smear microscopy and culture in Uganda. J Clin Microbiol. 2008 Oct;46(10):3325-9. Epub 2008 Aug 13. PMID: 18701657 [PubMed - indexed for MEDLINE] 22. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife KH, de Bruyn G, Gray GE, McIntyre JA, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Stevens W, Campbell MS, Thomas KK, Coombs RW, Morrow R, Whittington WL, McElrath MJ, Barnes L, Ridzon R, Corey L; Partners in Prevention HSV/HIV Transmission Study Team. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010 Feb 4;362(5):427-39. Epub 2010 Jan 20. PMID: 20089951[PubMed - indexed for MEDLINE] 23. Colebunders R, Worodria W, Jones-L├│pez E, Joloba M, Apers L, Ellner J. Drug-resistant TB and HIV in resource-limited settings: what TB/HIV programmes can learn from each other. Trop Med Int Health. 2008 Sep;13(9):1204-7. Epub 2008 Jul 28. PMID: 18664238 [PubMed - indexed for MEDLINE] 24. Dickman KR, Nabyonga L, Kateete DP, Katabazi FA, Asiimwe BB, Mayanja HK, Okwera A, Whalen C, Joloba ML. Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda. BMC Infect Dis. 2010 Dec 10;10:349. PMID: 21143966 [PubMed - indexed for MEDLINE] 25. Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium.Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. Epub 2009 Apr 30. PMID: 19406981 [PubMed - indexed for MEDLINE] 26. Filliol I, Motiwala AS, Cavatore M, Qi W, Hazb├│n MH, Bobadilla del Valle M, Fyfe J, Garc├¡a-Garc├¡a L, Rastogi N, Sola C, Zozio T, Guerrero MI, Le├│n CI, Crabtree J, Angiuoli S, Eisenach KD, Durmaz R, Joloba ML, Rend├│n A, Sifuentes-Osornio J, Ponce de Le├│n A, Cave MD, Fleischmann R, Whittam TS, Alland D. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol. 2006 Jan;188(2):759-72. Erratum in: J Bacteriol. 2006 Apr;188(8):3162-3. 16385065 [PubMed - indexed for MEDLINE] 27. Hirsch CS, Toossi Z, Johnson JL, Luzze H, Ntambi L, Peters P, McHugh M, Okwera A, Joloba M, Mugyenyi P, Mugerwa RD, Terebuh P, Ellner JJ. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis. 2001 Mar 1;183(5):779-88. Epub 2001 Feb 8. PMID: 11181155 [PubMed - indexed for MEDLINE] 28. Joloba ML, Kidenya BR, Kateete DP, Katabazi FA, Muwanguzi JK, Asiimwe BB, Alarakol SP, Nakavuma JL, Bajaksouzian S, Windau A, Jacobs MR. Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes. Int J Antimicrob Agents. 2010 Aug;36(2):124-8. Epub 2010 May 15. PMID: 20472405[PubMed - indexed for MEDLINE] 29. Joloba ML, Clemmer KM, Sledjeski DD, Rather PN. Activation of the gab operon in an RpoS-dependent manner by mutations that truncate the inner core of lipopolysaccharide in Escherichia coli. J Bacteriol. 2004 Dec;186(24):8542-6. PMID: 15576807 [PubMed - indexed for MEDLINE] 30. Joloba ML, Rather PN. Mutations in deoB and deoC alter an extracellular signaling pathway required for activation of the gab operon in Escherichia coli. FEMS Microbiol Lett. 2003 Nov 7;228(1):151-7. PMID: 14612251 [PubMed - indexed for MEDLINE] 31. Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, Jacobs MR. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis. 2001 Nov 1;33(9):1489-94. Epub 2001 Oct 4. PMID: 11588694 [PubMed - indexed for MEDLINE] 32. Joloba ML, Bajaksouzian S, Palavecino E, Whalen C, Jacobs MR. High prevalence of carriage of antibiotic-resistant Streptococcus pneumoniae in children in Kampala Uganda. Int J Antimicrob Agents. 2001 May;17(5):395-400. PMID: 11337227 [PubMed - indexed for MEDLINE] 33. Joloba ML, Johnson JL, Namale A, Morrissey A, Assegghai AE, R├╝sch-Gerdes S, Mugerwa RD, Ellner JJ, Eisenach KD. Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2001 Jun;5(6):579-82. PMID: 11409588 [PubMed - indexed for MEDLINE] 34. Joloba ML, Bajaksouzian S, Jacobs MR. Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2000 Oct;38(10):3834-6. PMID: 11015413 [PubMed - indexed for MEDLINE] 35. Joloba ML, Johnson JL, Namale A, Morrissey A, Assegghai AE, Mugerwa RD, Ellner JJ, Eisenach KD. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000 Jun;4(6):528-36. PMID: 10864183 [PubMed - indexed for MEDLINE] 36. Joloba ML, Whalen CC, Cave DM, Eisenach KD, Johnson JL, Okwera A, Morrissey A, Bajaksouzian S, Feagin J, Mugerwa R, Ellner J, Jacobs MR. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda. East Afr Med J. 2000 Feb;77(2):111-5. PMID: 10774085 [PubMed - indexed for MEDLINE] 37. Jones-L├│pez EC, Ayakaka I, Levin J, Reilly N, Mumbowa F, Dryden-Peterson S, Nyakoojo G, Fennelly K, Temple B, Nakubulwa S, Joloba ML, Okwera A, Eisenach KD, McNerney R, Elliott AM, Ellner JJ, Smith PG, Mugerwa RD. Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.PLoS Med. 2011 Mar;8(3):e1000427. Epub 2011 Mar 15.PMID:21423586[PubMed - indexed for MEDLINE] 38. Kateete DP, Namazzi S, Okee M, Okeng A, Baluku H, Musisi NL, Katabazi FA, Joloba ML, Ssentongo R, Najjuka FC. High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda.BMC Res Notes. 2011 Sep 7;4:326.PMID:21899769[PubMed] 39. Kateete DP, Okee M, Katabazi FA, Okeng A, Asiimwe J, Boom HW, Eisenach KD, Joloba ML.Rhomboid homologs in mycobacteria: insights from phylogeny and genomic analysis. BMC Microbiol. 2010 Oct 29;10:272. PMID: 21029479 [PubMed - indexed for MEDLINE] 40. Kateete DP, Kimani CN, Katabazi FA, Okeng A, Okee MS, Nanteza A, Joloba ML, Najjuka FC. Identification of Staphylococcus aureus: DNase and Mannitol salt agar improve the efficiency of the tube coagulase test. Ann Clin Microbiol Antimicrob. 2010 Aug 13;9:23. PMID: 20707914 [PubMed - indexed for MEDLINE] 41. Kirimuhuzya C, Waako P, Joloba M, Odyek O. The anti-mycobacterial activity of Lantana camara a plant traditionally used to treat symptoms of tuberculosis in South-western Uganda. Afr Health Sci. 2009 Mar;9(1):40-5. PMID: 20842241 [PubMed - indexed for MEDLINE] 42. Li L, Mahan CS, Palaci M, Horter L, Loeffelholz L, Johnson JL, Dietze R, Debanne SM, Joloba ML, Okwera A, Boom WH, Eisenach KD. 43. Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy. J Clin Microbiol. 2010 Jan;48(1):46-51. Epub 2009 Nov 18. PMID: 19923475 [PubMed - indexed for MEDLINE] 44. Lingappa J, Nakku-Joloba E, Magaret A, Friedrich D, Dragavon J, Kambugu F, Joloba M, Whalen C, Coombs R, Celum C, Morrow RA. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans. Int J STD AIDS. 2010 Sep;21(9):611-6. PMID: 21097732 [PubMed - indexed for MEDLINE] 45. Lukoye D, Cobelens FG, Ezati N, Kirimunda S, Adatu FE, Lule JK, Nuwaha F, Joloba ML. Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection. PLoS One. 2011 Jan 10;6(1):e16130. PMID: 21249225 [PubMed - indexed for MEDLINE] 46. Luzze H, Elliott AM, Joloba ML, Odida M, Oweka-Onyee J, Nakiyingi J, Quigley M, Hirsch C, Mugerwa RD, Okwera A, Johnson JL. Evaluation of suspected tuberculous pleurisy: clinical and diagnostic findings in HIV-1-positive and HIV-negative adults in Uganda. Int J Tuberc Lung Dis. 2001 Aug;5(8):746-53. PMID: 11495266 [PubMed - indexed for MEDLINE] 47. Mahan CS, Zalwango S, Thiel BA, Malone LL, Chervenak KA, Baseke J, Dobbs D, Stein CM, Mayanja H, Joloba M, Whalen CC, Boom WH.Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda. Am J Trop Med Hyg. 2012 Apr;86(4):690-7. PMID: 22492155 [PubMed - indexed for MEDLINE] 48. Mahapatra S, Woolhiser LK, Lenaerts AJ, Johnson JL, Eisenach KD, Joloba ML, Boom WH, Belisle JT. A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct. Antimicrob Agents Chemother. 2012 Jan;56(1):28-35. Epub 2011 Oct 28. PMID: 22037847 [PubMed - in process] 49. Mshana SE, Joloba ML, Kakooza A, Kaddu-Mulindwa D. Role of microscopic examination of stool specimens in the diagnosis of campylobacter infection from children with acute diarrhoea in Kampala, Uganda. Tanzan J Health Res. 2010 Jan;12(1):100-3. PMID: 20737835 [PubMed - indexed for MEDLINE] 50. Mshana SE, Joloba M, Kakooza A, Kaddu-Mulindwa D. Campylobacter spp among children with acute diarrhea attending Mulago hospital in Kampala--Uganda. Afr Health Sci. 2009 Sep;9(3):201-5. PMID:20589152[PubMed - indexed for MEDLINE] 51. Muchwa C, Akol J, Etwom A, Morgan K, Orikiriza P, Mumbowa F, Odong PR, Kateete DP, Eisenach KD, Joloba ML. Evaluation of Capilia TB assay for rapid identification of Mycobacterium tuberculosis complex in BACTEC MGIT 960 and BACTEC 9120 blood cultures. BMC Res Notes. 2012 Jan 19;5(1):44. PMID: 22260090 [PubMed - in process] 52. Muhumuza J, Asiimwe BB, Kayes S, Mugyenyi R, Whalen C, Mugerwa RD, Boom H, Eisenach KD, Joloba ML. Introduction of an in-house PCR for routine identification of M. tuberculosis in a low-income country. Int J Tuberc Lung Dis. 2006 Nov;10(11):1262-7. PMID: 17131786 [PubMed - indexed for MEDLINE] 53. Nabyonga L, Kateete DP, Katabazi FA, Odong PR, Whalen CC, Dickman KR, Moses JL. Determination of circulating Mycobacterium tuberculosis strains and transmission patterns among pulmonary TB patients in Kawempe municipality, Uganda, using MIRU-VNTR. BMC Res Notes. 2011 Aug 11;4:280. PMID: 21835016 [PubMed - in process] 54. Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M; Tuberculosis Trials Consortium. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One. 2010 May 20;5(5):e10753. PMID: 20505778 [PubMed - indexed for MEDLINE] 55. Nawaz F, Nsobya SL, Kiggundu M, Joloba M, Rosenthal PJ. Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda. J Infect Dis. 2009 Dec 1;200(11):1650-7. PMID: 19905933 [PubMed - indexed for MEDLINE] 56. Niemann S, Kubica T, Bange FC, Adjei O, Browne EN, Chinbuah MA, Diel R, Gyapong J, Horstmann RD, Joloba ML, Meyer CG, Mugerwa RD, Okwera A, Osei I, Owusu-Darbo E, Schwander SK, R├╝sch-Gerdes S. The species Mycobacterium africanum in the light of new molecular markers. J Clin Microbiol. 2004 Sep;42(9):3958-62. PMID: 15364975 [PubMed - indexed for MEDLINE] 57. Niemann S, R├╝sch-Gerdes S, Joloba ML, Whalen CC, Guwatudde D, Ellner JJ, Eisenach K, Fumokong N, Johnson JL, Aisu T, Mugerwa RD, Okwera A, Schwander SK. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol. 2002 Sep;40(9):3398-405. PMID: 12202584 [PubMed - indexed for MEDLINE] 58. Nsobya SL, Kiggundu M, Nanyunja S, Joloba M, Greenhouse B, Rosenthal PJ.In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob Agents Chemother. 2010 Mar;54(3):1200-6. Epub 2010 Jan 11. PMID: 20065051 [PubMed - indexed for MEDLINE] 59. Nsobya SL, Kiggundu M, Joloba M, Dorsey G, Rosenthal PJ. Complexity of Plasmodium falciparum clinical samples from Uganda during short-term culture. J Infect Dis. 2008 Nov 15;198(10):1554-7. PMID: 18808336 [PubMed - indexed for MEDLINE] 60. Nsobya SL, Dokomajilar C, Joloba M, Dorsey G, Rosenthal PJ. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda. Antimicrob Agents Chemother. 2007 Aug;51(8):3023-5. Epub 2007 Jun 11. PMID: 17562798 [PubMed - indexed for MEDLINE] 61. Ogwang S, Asiimwe BB, Traore H, Mumbowa F, Okwera A, Eisenach KD, Kayes S, Jones-L├│pez EC, McNerney R, Worodria W, Ayakaka I, Mugerwa RD, Smith PG, Ellner J, Joloba ML Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda. BMC Infect Dis. 2009 Aug 26;9:139. PMID: 19709423 [PubMed - indexed for MEDLINE] 62. Ojulong J, Mwambu TP, Joloba M, Bwanga F, Kaddu-Mulindwa DH. Relative prevalence of methicilline resistant Staphylococcus aureus and its susceptibility pattern in Mulago Hospital, Kampala, Uganda. Tanzan J Health Res. 2009 Jul;11(3):149-53. PMID: 20734712 [PubMed - indexed for MEDLINE] 63. Okee MS, Joloba ML, Okello M, Najjuka FC, Katabazi FA, Bwanga F, Nanteza A, Kateete DP Prevalence of virulence determinants in Staphylococcus epidermidis from ICU patients in Kampala, Uganda. J Infect Dev Ctries. 2012 Mar 12;6(3):242-50. PMID: 22421605 [PubMed - in process] 64. Palavecino EL, Riedel I, Duran C, Bajaksouzian S, Joloba M, Davies T, Appelbaum PC, Jacobs MR. Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile. Int J Antimicrob Agents. 2002 Aug;20(2):108-12. PMID: 12297359 [PubMed - indexed for MEDLINE] 65. Ssali FN, Kamya MR, Wabwire-Mangen F, Kasasa S, Joloba M, Williams D, Mugerwa RD, Ellner JJ, Johnson JL. A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):484-9. PMID: 9859962 [PubMed - indexed for MEDLINE] 66. Ssengooba W, Kiwanuka N, Kateete DP, Katamba A, Joloba ML. Incremental Yield of Serial Sputum Cultures for Diagnosis of Tuberculosis among HIV Infected Smear Negative Pulmonary TB Suspects in Kampala, Uganda. PLoS One. 2012;7(5):e37650. Epub 2012 May 22. PMID: 22629439 [PubMed - in process] 67. Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, Nakubulwa S, Worodria W, Levin J, Joloba M, Okwera A, Eisenach KD, McNerney R, Elliott AM, Smith PG, Mugerwa RD, Ellner JJ, Jones-L├│pez EC. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis. 2008 Nov 1;47(9):1126-34. PMID: 18808360 [PubMed - indexed for MEDLINE] 68. Toossi Z, Johnson JL, Kanost RA, Wu M, Luzze H, Peters P, Okwera A, Joloba M, Mugyenyi P, Mugerwa RD, Aung H, Ellner JJ, Hirsch CS. Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):1-8. PMID: 11579270 [PubMed - indexed for MEDLINE] 69. Traore H, Ogwang S, Mallard K, Joloba ML, Mumbowa F, Narayan K, Kayes S, Jones-Lopez EC, Smith PG, Ellner JJ, Mugerwa RD, Eisenach KD, McNerney R. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob. 2007 Jan 9;6:1. PMID: 17212825 [PubMed - indexed for MEDLINE] 70. Wallis RS, Perkins MD, Phillips M, Joloba M, Namale A, Johnson JL, Whalen CC, Teixeira L, Demchuk B, Dietze R, Mugerwa RD, Eisenach K, Ellner JJ. Predicting the outcome of therapy for pulmonary tuberculosis. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1076-80. PMID: 10764293 [PubMed - indexed for MEDLINE] 71. Wallis RS, Patil S, Cheon SH, Edmonds K, Phillips M, Perkins MD, Joloba M, Namale A, Johnson JL, Teixeira L, Dietze R, Siddiqi S, Mugerwa RD, Eisenach K, Ellner JJ. Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1999 Nov;43(11):2600-6. PMID: 10543735 [PubMed - indexed for MEDLINE] 72. Wallis RS, Perkins M, Phillips M, Joloba M, Demchuk B, Namale A, Johnson JL, Williams D, Wolski K, Teixeira L, Dietze R, Mugerwa RD, Eisenach K, Ellner JJ. Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment. J Infect Dis. 1998 Oct;178(4):1115-21. PMID: 9806042 [PubMed - indexed for MEDLINE] 73. Whalen CC, Zalwango S, Chiunda A, Malone L, Eisenach K, Joloba M, Boom WH, Mugerwa R.Secondary attack rate of tuberculosis in urban households in Kampala, Uganda. PLoS One. 2011 Feb 14;6(2):e16137. PMID: 21339819 [PubMed - indexed for MEDLINE] 74. Worodria W, Anderson J, Cattamanchi A, Davis JL, den Boon S, Andama A, Yoo SD, Joloba M, Huang L, Kato-Maeda M. The role of speciation in positive Lowenstein-Jensen culture isolates from a high tuberculosis burden country. PLoS One. 2011;6(11):e27017. Epub 2011 Nov 4. PMID: 22073241 [PubMed - indexed for MEDLINE] 75. Yoshimine H, Oishi K, Mubiru F, Nalwoga H, Takahashi H, Amano H, Ombasi P, Watanabe K, Joloba M, Aisu T, Ahmed K, Shimada M, Mugerwa R, Nagatake T. Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia. Am J Trop Med Hyg. 2001 Mar-Apr;64(3-4):172-7. PMID: 11442214 [PubMed - indexed for MEDLINE]